PAO Group Inc (PAOG)

[HNDRXX]

$PAOG: NCM BIOTECH ACQUSITON (COVID TREATMENT), Cannabis Cultivation Patent, $PURA dividend 1-1

After conducting further due diligence i bring to you my findings of what appears to be a mega runner in the making as PAOG's NCM Biotech Acqusition was recently contacted by the National Health Institute. Dots seem to be connecting that NCM Biotech May be in the works of developing some kind of Covid treatment for the Pandemic We are Currently Facing. NCM Biotech according to information posted on the webpage has already reached out to the Bill & Melinda Gates Foundation Please Review the DD below and understand what is NCM Biotech and why it is important that this deal closes tomorrow.





Pending Events
1. Filings With OTC Markets to Return to Pink Current
2. New Website Pending Reflecting the Revitalization Plan
3. Two Pending Acquisitions (NCM Biotech Patented Cannabis Extraction Operation)
4. recently purchased and relocated to a new property [/color]

Extraction Patent: https://patents.google.com/patent/US9199960B2/en

Authorized Shares 1,500,000,000
Outstanding Shares 885,183,494
Website: https://www.ncmbiotech.com


NCM Biotech is a licensor of the highest quality hemp oil in the industry. Our cannabinoid levels surpass any standard levels on the market today. Currently, we are forming partnerships with retail providers of edible and topical application products. Please contact us to learn more!
NCM Biotech provides a self contained lab facility which meets the necessary requirements to produce our patented product.



On July 10, 2020, NCMBiotech was contacted directly from the National Institute of Health director of operations Dina Mikdadi for it's recognition of it's patented all natural NCMB-1 compound, which is a documented viable treatment not just for COVID-19 but other ailments as well. NCMBiotech is proud to announce it's official application has been submitted to the NIH and is looking forward to a partnership with NIH to help stop the spread of COVID-19 and other ailments of mankind.

Reference LINK">Reference LINK" />

https://ec3d84fd-f987-4001-afb5-ae8cd950a551.filesusr.com/ugd/661caa_e07e1088584b46a98191b466b26b9978.pdf

https://ec3d84fd-f987-4001-afb5-ae8cd950a551.filesusr.com/ugd/661caa_e4c8303a0b384502a69bbdd58b2e6bd0.pdf

Founder of NCM Biotech: Frederick Ferri




https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-019-0014-9

The Journal of Cannabis Research to publish The "Effects of Cannabis Oil Extract on Immune Response Gene Expression in Human Small Airway Epithelial Cells (HSAEpC): Implications for Chronic Obstructive Pulmonary Disease (COPD)" manuscript. The manuscript was written in collaboration by Stephen Mamber, Volkan Gurel, Jeremy Lins, Frederick Ferri, Sarah Beseme and John McMichael.

PURA produces EVERx CBD Sports Water, the leading CBD infused water within the sports nutrition market. PURA has over $1 million annual sales and a $4 million revenue target for 2019










PAOG is also working to launch an all new website that reflects its revitalization plan to include more information on the two pending acquisitions.


Dallas, Texas--(Newsfile Corp. - July 14, 2020) - Puration, Inc. (OTC Pink: PURA) today highlighted the completion of the first step in a multistep deal to reposition its cannabis cultivation spinoff and issue a dividend to shareholders. See the news below released by PAO Group, Inc. (OTC Pink: PAOG). The management takeover announced by PAOG is the first step intended to lead to the acquisition by PAOG of PURA's cannabis cultivation spinoff and merger with Kali-Extracts' (KALY) NCM Biotech. The PAOG plan with PURA and KALY includes a dividend distribution of PAOG stock to PURA shareholders. See details in the news released earlier today by PAOG:



PURA’s cannabis cultivation operation is thriving, has revenue, and has recently purchased and relocated to a new property from its former leased property. Texas lawmakers have recently implemented hemp friendly farming regulations and in so doing, universities within the State of Texas have initiated hemp farming research programs. PURA's cannabis cultivation spinoff has initiated a number of joint research applications with Texas universities.

Dallas, TX -- July 27, 2020 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today confirmed the cannabis cultivation deal with PAO Group, Inc. (USOTC: PAOG) is expected to close tomorrow, July 28, 2020. PAOG Group is acquiring PURA’s cannabis cultivation operation in exchange for PAOG common stock. The PAOG stock issued to PURA is to be issued to PURA shareholders in a dividend distribution. The target dividend ratio is for each PURA shareholder to receive one share of PAOG stock for each share of PURA held.

PAOG also intends to acquire NCM Biotech from Kali-Extracts, Inc. (KALY). NCM Biotech is focused on medical research and the development of treatments derived from its patented cannabis extraction process.

NCM Biotech has patented cannabis extraction operation which is focused on medical research and the development of treatments derived from its patented cannabis extraction process. See a recent research report on CBD extracts derived from NCM Biotech's patented extraction process: Journal of Cannabis Research.

PURA’s cannabis cultivation operation is thriving, has revenue, and has recently purchased and relocated to a new property from its former leased property. Texas lawmakers have recently implemented hemp friendly farming regulations and in so doing, universities within the State of Texas have initiated hemp farming research programs. PURA's cannabis cultivation spinoff has initiated a number of joint research applications with Texas universities.

PURA had previously spun-off its cannabis cultivation operation to Nouveau (USOTC: NOUV) and is now unwinding that deal to move forward with PAOG.

For more information on Puration, visit https://www.purationinc.com